TITLE

Quantum Leaps, Microeconomics, and the Treatment of Patients With Hepatitis C and HIV Coinfection

AUTHOR(S)
Saag, Michael S.
PUB. DATE
July 2014
SOURCE
JAMA: Journal of the American Medical Association;7/23/2014, Vol. 312 Issue 4, p347
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
An introduction is presented in which the editor discusses microeconomics, quantum leap mechanics, and the treatment of patients with hepatitis C virus (HCV) and HIV coinfection, published in the July 23/30, 2014 issue of the "Journal of American Medical Association" (JAMA).
ACCESSION #
97186192

 

Related Articles

  • Therapeutic Interventions for HIV Infection and Chronic Viral Hepatitis. Cooper, Curtis L. // Clinical Infectious Diseases;7/1/2005 Supplement, Vol. 41, pS69 

    Combination antiretroviral therapy reduces overall and liver-specific morbidity and mortality in coinfection with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) and represents the most beneficial pharmaceutical treatment intervention for most coinfected patients. Antiviral...

  • Abnormal Cytokine Production by Circulating Monocytes and Dendritic Cells of Myeloid Origin in ART-Treated HIV-1+ Patients Relates to CD4+ T-Cell Recovery and HCV Co-Infection. Almeida, Maria; Cordero, Miguel; Almeida, Julia; Orfao, Alberto // Current HIV Research;Jul2007, Vol. 5 Issue 3, p325 

    HIV-1 infection is associated with dysregulation of cytokine production by peripheral blood (PB) monocytes and dendritic cells (DC), but controversial results have been reported. We aimed to analyze the effect of antiretroviral therapy (ART) on the in vitro production of inflammatory cytokines...

  • Deciphering the Interleukin 28B Variants That Better Predict Response to Pegylated Interferon-a and Ribavirin Therapy in HCV/HIV-1 Coinfected Patients. de Castellarnau, Montserrat; Aparicio, Ester; Parera, Mariona; Franco, Sandra; Tural, Cristina; Clotet, Bonaventura; Mart´┐Żnez, Miguel Angel // PLoS ONE;Feb2012, Vol. 7 Issue 2, p1 

    Previous works have documented the contribution of different IL28B-associated SNPs to spontaneous HCV clearance. This study investigated the effect of different interleukin (IL) 28B genetic variants on interferon (IFN)-based therapy response. We genotyped eight IL28B single-nucleotide...

  • HIV-HCV co-infection: epidemiology, pathogenesis and therapeutic implications. ANDREONI, M.; GIACOMETTI, A.; MAIDA, I.; MERAVIGLIA, P.; RIPAMONTI, D.; SARMATI, L. // European Review for Medical & Pharmacological Sciences;2012, Vol. 16 Issue 11, p1473 

    Hepatitis C virus (HCV) is the cause of more than three-quarters of liver-related deaths in HIV-seropositive individuals and it is remarkable that today approximately one-quarter of HIV-infected individuals in Europe and the USA have a HCV coinfection. HIV/HCV coinfected patients were more...

  • A Call for Routine HIV Testing Among Patients with Hepatitis C Virus Infection. Taylor, Lynn E.; Gaitanis, Melissa M.; Beckwith, Curt G. // Open Infectious Diseases Journal;2011, Vol. 5, p97 

    The authors discuss aspects of routine HIV testing among patients infected with hepatitis C virus. They refer to studies that found overly high HIV prevalence in HCV-infected patients and high threshold prevalence of undiagnosed HIV infection due to inadequate routine testing. The authors...

  • Genetic Characterization of Hepatitis C Viruses in HIV Positive People who Inject Drugs, Dhaka, Bangladesh. Rahman, Mustaizur; Chowdhury, Ezazul Islam; Reza, Masud; Alam, Md Shah; Sarker, M. Saiullah; Afrad, Mokibul Hassan; Alam, Muntasir; Rahman, M. Ziaur; Pourkarim, Mahmoud Reza; Azim, Tasnim // Journal of AIDS & Clinical Research;2012, Vol. 3 Issue 7, p1 

    We investigated the HCV genotypes in HIV positive people who inject drugs (PWID) identiied in Dhaka, Bangladesh in 2003. Genetic analyses revealed that the PWIDs shared closely related HIV strains subtype C genotypes but HCV genotypes in them were distantly related. This indicates that the mode...

  • HIV-positive people with HCV have worse response to first antiretroviral combination.  // HIV Treatment ALERTS!;Mar2014, p36 

    The article presents a study on the impact of hepatitis C virus (HCV) in people with HIV infection. The researchers applied accepted statistical methods to identify how HCV impacted response to antiretrovirals examined by four results. The study reveals that people with HCV and HIV gained fewer...

  • ANTI-AIDS VIRUS. Stoppani, Jim // Joe Weider's Muscle & Fitness;Jun2004, Vol. 65 Issue 6, p234 

    Discusses research being done on anti-AIDS virus as of June 2004. Purpose of inactivated viruses to patients; Observations made by scientists from the National Institute of Allergy and Infectious Diseases on the effect of GB virus C on HIV-infected patients; Assumption on a previously-released...

  • Acute HCV in HIV-Positive Individuals -- A Review. Danta, M.; Dusheiko, G. M. // Current Pharmaceutical Design;Jun2008, Vol. 14 Issue 17, p1690 

    HCV/HIV co-infection is a major public health problem with between 10-25% of HIV-positive individuals infected with HCV. Following the introduction of effective HIV therapies, HCV has become a leading cause of morbidity and mortality in the HIV population. Since the early 2000s, there has been a...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics